Loading Peptellect…
Loading Peptellect…
Peptides · CU50
£34.99excl. VAT
50 mgFree vial: order any 3 vials and the lowest-priced one is free.
For laboratory research use only. Not for human or veterinary use. Not for consumption, administration, diagnosis, treatment, or prevention of disease.
GHK-Cu refers to a copper-associated glycyl-histidyl-lysine peptide system.
Overview and specificationsGHK-Cu refers to a copper-associated glycyl-histidyl-lysine peptide system. Foundational experiments examined collagen synthesis in fibroblast cultures. Copper coordination, ligand ratio and chemical form matter when matching a reference to a supplied material.
The literature describes an experimental compound or formulation. Matching it to a research material requires the exact sequence or structure, chemical form, modifications and appropriate batch records. A matching name alone cannot make that connection.
The supplied amount is 50 mg. Batch identity, purity, storage and handling should be established from the material-specific COA and safety documentation before laboratory evaluation.
Reference chemistry describes a database compound. It is not a measurement or certification of the material in this vial.
Lingda Laboratory report LDA-2216-2351, issued 18 October 2026. Chromatographic purity (HPLC): >99.38% ± 0.18%. Quantity (HPLC): 50.12 mg. The certificate covers the batch tested; match the lot on your vial to it. Open full size
Match product identity and lot number first. Then review analytical methods, reported results, acceptance criteria and the issuing laboratory. A certificate for another batch does not establish this batch’s properties.
Use the SDS and batch documentation for the exact material, formulation and container. Storage and reconstitution instructions have not been confirmed for this entry; do not infer them from a similarly named product.
No. Materials are exclusively for laboratory research, not consumption, self-experimentation, human or veterinary administration, diagnosis, treatment or prevention of disease.
Unresolved identity, composition or analytical information requires clarification before a material can be evaluated for supply.
Scientific Advisory Board
Chaired by neuroscientist Dr Steve Ray, our Scientific Advisory Board brings decades of research in regenerative medicine and cell biology to the specifications we publish for every research compound.
